Categories
News Virus watch in the news Virus watch results

Study finds a significant reduction in the risk of COVID-19 infection among those who always wear glasses.

A woman wearing glasses taking off a mask
Image Credit: DimaBerlin/Shutterstock

This study hypothesized and evaluated the use of spectacles in a community context for minimizing the likelihood of COVID-19. 

Among the 58,670 volunteers of the Virus Watch cohort, the researchers invited 31,749 participants to answer a monthly survey about contact lenses and spectacle use, and 19,166 responded to this questionnaire. The questionnaire covered topics including purpose, frequency of use, and probability of using a face mask with spectacles.

While 22.99% of people who never wore spectacles for general use had COVID-19, only 15.63% of those who constantly wore spectacles for regular use were SARS-CoV-2-infected. The multivariate regression model controlled for gender, income, age, and occupation and depicted a 15% lower chance of COVID-19 for individuals who reported wearing spectacles constantly for general usage than people who had never worn spectacles. A similar observation was found in those using spectacles always for reading and other particular activities.

The study findings demonstrated that individuals who use spectacles had a lower chance of SARS-CoV-2 infection than non-spectacle users. However, the protective effect against COVID-19 was not observed in contact lens users. 

Overall, the present research indicates the relevance of the eye as a portal for SARS-CoV-2 infection. The authors found a moderate decline in the chance of COVID-19 in individuals who wore spectacles. This research extrapolated the existing evidence of the SARS-CoV-2 infection through the eyes in the hospital setting to a community context. 

This work has been reported on here:

https://www.news-medical.net/news/20220407/Study-finds-a-significant-reduction-in-the-risk-of-COVID-19-infection-among-those-who-always-wear-glasses.aspx

For a link to the full article please see: https://www.medrxiv.org/content/10.1101/2022.03.29.22272997v1